Skip to main content
Premium Trial:

Request an Annual Quote

Atossa Genetics Lab Gains CLIA Certification

NEW YORK (GenomeWeb News) – Breast cancer diagnostics developer Atossa Genetics said today that its breast health reference lab has received Clinical Laboratory Improvement Amendments certification from the Centers for Medicare and Medicaid Services.

The company's National Reference Laboratory for Breast Health subsidiary, located in Seattle, was certified after an inspection of its facilities, processes, and personnel, and a review of the validation and clinical reports from its lab-developed tests, and the ForeCyte and ArgusCyte Breast Health Tests.

The company's tests use molecular and cellular biomarkers for breast cancer risk, and are based on its Mammary Aspirate Specimen Cytology system, which enables nurses or physician assistants to collect samples in around 10 minutes.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.